Search Main Menu Main Content
  • Change contrast :
Haute Autorité de Santé
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

1 result

  • Topics : Population groups
  • Active substance : sulfadoxine
  • Date : du 30/05/2015 au 30/05/2019
Filter
Topic
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Diagnostic techniques and procedures (1)
    • Plus ...
      • Biology (laboratory tests) (1)
  • Diseases and conditions (1)
  • Plus ...
    • Infectious diseases (1)
    • Plus ...
      • Parasitic diseases and mycoses (1)
    • Pregnancy and reproduction (1)
    • Plus ...
      • Pregnancy (1)
  • Population groups (1)
  • Plus ...
    • Paediatrics (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Health technology assessment (1)
Date
  • Last five years (1)
Language
  • Français (1)
Active substance
  • acide ascorbique (1)
  • acide folinique (1)
  • acide folique (1)
  • atovaquone (1)
  • clindamycine (1)
  • spiramycine (1)
  • sulfadiazine (1)
  • sulfadoxine (1)
  • trypsine (1)

Drugs, devices and medical acts - 1 result

  • Laboratory diagnosis of acquired toxoplasmosis in immunocompetent subjects (including pregnant woman), congenital toxoplasmosis (pre- and postnatal diagnosis) and ocular toxoplasmosis - INAHTA Brief

    Health technology assessment - Posted on 13/2/2017
    Download document
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
ye6d1TcA5ekFpsQP